Peptides having reduced toxicity that stimulate cholesterol efflux
Abstract
The present invention provides a family of non-naturally occurring polypeptides having cholesterol efflux activity that parallels that of full-length apolipoproteins (e.g., Apo AI and Apo E), and having high selectivity for ABCA1 that parallels that of full-length apolipoproteins. Further, the peptides of the invention have little or no toxicity when administered at therapeutic and higher doses. The invention also provides compositions comprising such polypeptides, methods of identifying, screening and synthesizing such polypeptides, and methods of treating, preventing or diagnosing diseases and disorders associated with dyslipidemia, hypercholesterolemia and inflammation.
- Inventors:
- Issue Date:
- Research Org.:
- Lawrence Berkeley National Lab. (LBNL), Berkeley, CA (United States)
- Sponsoring Org.:
- USDOE
- OSTI Identifier:
- 1298004
- Patent Number(s):
- 9416162
- Application Number:
- 14/216,749
- Assignee:
- The Regents of the University of California (Oakland, CA)
- Patent Classifications (CPCs):
-
A - HUMAN NECESSITIES A61 - MEDICAL OR VETERINARY SCIENCE A61P - SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
C - CHEMISTRY C07 - ORGANIC CHEMISTRY C07K - PEPTIDES
- DOE Contract Number:
- AC02-05CH11231
- Resource Type:
- Patent
- Resource Relation:
- Patent File Date: 2014 Mar 17
- Country of Publication:
- United States
- Language:
- English
- Subject:
- 60 APPLIED LIFE SCIENCES; 59 BASIC BIOLOGICAL SCIENCES
Citation Formats
Bielicki, John K., Johansson, Jan, and Danho, Waleed. Peptides having reduced toxicity that stimulate cholesterol efflux. United States: N. p., 2016.
Web.
Bielicki, John K., Johansson, Jan, & Danho, Waleed. Peptides having reduced toxicity that stimulate cholesterol efflux. United States.
Bielicki, John K., Johansson, Jan, and Danho, Waleed. Tue .
"Peptides having reduced toxicity that stimulate cholesterol efflux". United States. https://www.osti.gov/servlets/purl/1298004.
@article{osti_1298004,
title = {Peptides having reduced toxicity that stimulate cholesterol efflux},
author = {Bielicki, John K. and Johansson, Jan and Danho, Waleed},
abstractNote = {The present invention provides a family of non-naturally occurring polypeptides having cholesterol efflux activity that parallels that of full-length apolipoproteins (e.g., Apo AI and Apo E), and having high selectivity for ABCA1 that parallels that of full-length apolipoproteins. Further, the peptides of the invention have little or no toxicity when administered at therapeutic and higher doses. The invention also provides compositions comprising such polypeptides, methods of identifying, screening and synthesizing such polypeptides, and methods of treating, preventing or diagnosing diseases and disorders associated with dyslipidemia, hypercholesterolemia and inflammation.},
doi = {},
journal = {},
number = ,
volume = ,
place = {United States},
year = {2016},
month = {8}
}
Works referenced in this record:
Protein Folding: A Glimpse of the Holy Grail?
journal, October 1998
- Berendsen, H. J. C.
- Science, Vol. 282, Issue 5389, p. 642-643
Limits of Cooperativity in a Structurally Modular Protein: Response of the Notch Ankyrin Domain to Analogous Alanine Substitutions in Each Repeat
journal, November 2002
- Bradley, Christina Marchetti; Barrick, Doug
- Journal of Molecular Biology, Vol. 324, Issue 2, p. 373-386
Computational Complexity, Protein Structure Prediction, and the Levinthal Paradox
book, January 1994
- Ngo, J. Thomas; Marks, Joe; Karplus, Martin
- The Protein Folding Problem and Tertiary Structure Prediction, p. 433-506
The complete genome sequence of Moorella thermoacetica (f. Clostridium thermoaceticum)
journal, July 2008
- Pierce, Elizabeth; Xie, Gary; Barabote, Ravi D.
- Environmental Microbiology, Vol. 10, Issue 10, p. 2550-2573
Sustained-delivery of an apolipoproteinE–peptidomimetic using multivesicular liposomes lowers serum cholesterol levels
journal, February 2002
- Ramprasad, Mysore P.; Anantharamaiah, G. M.; Garber, David W.
- Journal of Controlled Release, Vol. 79, Issue 1-3, p. 207-218
Characteristics of the amino acids as components of a peptide hormone sequence
book, January 1976
- Rudinger, J.; Parsons, J. A.
- Peptide Hormones, p. 1-7
Effects of l- or d-Pro incorporation into hydrophobic or hydrophilic helix face of amphipathic α-helical model peptide on structure and cell selectivity
journal, February 2004
- Song, Yun Mi; Yang, Sung-Tae; Lim, Shin Saeng
- Biochemical and Biophysical Research Communications, Vol. 314, Issue 2, p. 615-621
Apolipoprotein E: phospholipid binding studies with synthetic peptides from the carboxyl terminus
journal, February 1992
- Sparrow, James T.; Sparrow, Doris A.; Fernando, Germain
- Biochemistry, Vol. 31, Issue 4, p. 1065-1068
The C-Terminal Lipid-Binding Domain of Apolipoprotein E Is a Highly Efficient Mediator of ABCA1-Dependent Cholesterol Efflux that Promotes the Assembly of High-Density Lipoproteins
journal, March 2007
- Vedhachalam, Charulatha; Narayanaswami, Vasanthy; Neto, Nicole
- Biochemistry, Vol. 46, Issue 10, p. 2583-2593
Regulation and Mechanisms of ATP-Binding Cassette Transporter A1-Mediated Cellular Cholesterol Efflux
journal, July 2003
- Wang, N.
- Arteriosclerosis, Thrombosis, and Vascular Biology, Vol. 23, Issue 7, p. 1178-1184